United States - English - NLM (National Library of Medicine)

meridian medical technologies, inc. - hydroxocobalamin (unii: q40x8h422o) (hydroxocobalamin - unii:q40x8h422o) - hydroxocobalamin 5 g in 250 ml - cyanokit is indicated for the treatment of known or suspected cyanide poisoning. none risk summary available data from cases reported in the published literature and postmarketing surveillance with cyanokit use in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal and fetal outcomes. there are risks to the pregnant woman and fetus associated with untreated cyanide poisoning (see clinical considerations) . in animal studies, hydroxocobalamin administered to pregnant rats and rabbits during the period of organogenesis caused skeletal and soft tissue abnormalities, including alterations in the central nervous system, at exposures similar to human exposures at the therapeutic dose (see data) . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated backgr

United States - English - NLM (National Library of Medicine)

btg international inc. - hydroxocobalamin (unii: q40x8h422o) (hydroxocobalamin - unii:q40x8h422o) - cyanokit is indicated for the treatment of known or suspected cyanide poisoning. none risk summary available data from cases reported in the published literature and postmarketing surveillance with cyanokit use in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal and fetal outcomes. there are risks to the pregnant woman and fetus associated with untreated cyanide poisoning (see clinical considerations) . in animal studies, hydroxocobalamin administered to pregnant rats and rabbits during the period of organogenesis caused skeletal and soft tissue abnormalities, including alterations in the central nervous system, at exposures similar to human exposures at the therapeutic dose (see data) . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated backgr

India - English - Central Drugs Standard Control Organization

merind - calcium carbonate,vit.d3,ferrous sulph.,folic acid - kit - 500mg,200iu.,150mg,0.5mg;kit - 6 kit

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - emodepside; praziquantel - topical solution/suspension - emodepside anthelmintic active 21.4 g/l; praziquantel anthelmintic active 85.8 g/l - parasiticides - cat - small | kitten - over 8 weeks - hookworm - ancylostoma tubaeforme | lungworm - cat | roundworm - toxascaris leonina | roundworm - toxocara cati | tapeworm - dipylidium caninum | tapeworm - taenia taeniaeformis | aelurostrongylus abstrusus | ascarid | human intestinal roundworm | mature stages of aelurostrongy | toxocara mystax

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - moxidectin; imidacloprid - topical solution/suspension - moxidectin anthelmintic active 10.0 g/l; imidacloprid guanidine active 100.0 g/l - parasiticides - cat - small | ferrets | kitten | young cat - flea | flea - larvae (ctenocephalides spp.) | flea allergic dermatitis | heartworm | heartworm - prevention of | hookworm | hookworm - ancylostoma tubaeforme | hookworm - uncinaria stenocephala | lungworm | roundworm - toxascaris leonina | roundworm - toxocara cati | ancylostoma braziliense | ancylostoma caninum | ascarid | ctenocephalides spp. | ground fleas | human intestinal roundworm | to prevent heartworm | toxocara mystax | uncinaria stenocephala

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid - topical solution/suspension - imidacloprid guanidine active 100.0 g/l - parasiticides - cat - up to 4kg | kitten | young cat - flea | flea - ctenocephalides spp. | flea - larvae (ctenocephalides spp.) | flea allergic dermatitis | ctenocephalides spp. | ground fleas

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - benzalkonium chloride - cutaneous spray, solution - 0.20 percent weight/weight - quaternary ammonium compounds

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - rhenium sulphide - kit for radiopharmaceutical preparation - milligram - technetium (99mtc), particles and colloids

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - sodium oxidronate - kit for radiopharmaceutical preparation - 3.0 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) oxidronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - dimercaptosuccinic acid - kit for radiopharmaceutical preparation - 1 mg - technetium (99mtc) compounds; technetium (99mtc) succimer